2022
Fact sheet
This fact sheet lists the quality statements for clinicians included in the Opioid Analgesic Stewardship in Acute Pain Clinical Care Standard.
2023
Fact sheet
This resource for consumers explains what each quality statement in the Opioid Analgesic Stewardship in Acute Pain Clinical Care Standard means for people presenting with acute pain to the emergency department or following in-patient surgery.
Purpose
To inform patients, and their family or carer, about the potential benefits and harms of acute pain treatment options so that they can participate in decision-making about their treatment with their clinician. This may or may not include opioid analgesics.
Endorsements
The Opioid Analgesic Stewardship in Acute Pain Clinical Care Standard was endorsed by the following organisations in 2022:
This was submitted last year but somehow not published
Indicator specifications
The definitions required to collect and calculate indicator data are specified in the Metadata Online Registry (METeOR).
2022
Corporate
On 21 March 2022, the Australian Commission on Safety and Quality in Health Care, the Aged Care Quality and Safety Commission and the NDIS Quality and Safeguards Commission have launched the Joint Statement on the important issue of inappropriate use of psychotropic medicines with people with disability and older people as a form of restrictive practice, and committed to collaborative action to reduce it.
Translations
2022
Fact sheet
To provide certainty for general practices, and facilitate accreditation assessments proceeding where possible, provisions for accreditation assessments will apply during 2022.
2022
Fact sheet
Developed by the Commission and endorsed by the Australian and New Zealand College of Anaesthetists this factsheet summarises the identification of neural route medicines, fluids and lines as described in the National standard for user-applied labelling of injectable medicines, fluids and lines.